17 related articles for article (PubMed ID: 8474622)
1. Dopamine D2/3 receptor antagonism reduces activity-based anorexia.
Klenotich SJ; Ho EV; McMurray MS; Server CH; Dulawa SC
Transl Psychiatry; 2015 Aug; 5(8):e613. PubMed ID: 26241351
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute and subchronic administration of propranolol on the social behaviour of mice; an ethopharmacological study.
Gao B; Cutler MG
Neuropharmacology; 1992 Aug; 31(8):749-56. PubMed ID: 1528404
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute and chronic administration of the antidepressants, imipramine, phenelzine and mianserin, on the social behaviour of mice.
Gao B; Cutler MG
Neuropharmacology; 1994 Jun; 33(6):813-24. PubMed ID: 7936119
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage.
Gao B; Cutler MG
Neuropharmacology; 1992 Aug; 31(8):743-8. PubMed ID: 1356251
[TBL] [Abstract][Full Text] [Related]
5. Buspirone increases social investigation in pair-housed male mice; comparison with the effects of chlordiazepoxide.
Gao B; Cutler MG
Neuropharmacology; 1993 May; 32(5):429-37. PubMed ID: 8321425
[TBL] [Abstract][Full Text] [Related]
6. Effects of sub-chronic treatment with chlordiazepoxide, buspirone and the 5-HT3 receptor antagonist, BRL 46470, on the social behaviour of mice.
Gao B; Cutler MG
Neuropharmacology; 1992 Mar; 31(3):207-13. PubMed ID: 1630589
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute and subchronic administration of ritanserin on the social behaviour of mice.
Gao B; Cutler MG
Neuropharmacology; 1993 Mar; 32(3):265-72. PubMed ID: 8474622
[TBL] [Abstract][Full Text] [Related]
8. Ritanserin and alcohol abuse and dependence.
Meert TF
Alcohol Alcohol Suppl; 1994; 2():523-30. PubMed ID: 8974378
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
